Pancreatic cancer halted by virus injection in three patients

(scienceinhand.com)

133 points | by cybermango 2 hours ago

7 comments

  • HedonicEscal8r 9 minutes ago
    Relevant recent paper from the lead researcher: https://doi.org/10.1158/1535-7163.MCT-25-1231

    Very early results, but it's exciting stuff. I am less confident in this specific trial working out than I am in some therapies in this field making significant progress in the next few years. (As usual, I am reminded how terribly slow research is for people that need treatments now.)

  • epistasis 35 minutes ago
    I was trying to figure out what the actual intervention was, and what clinical trial this is from based on the extremely limited information, and have not been able to yet.

    In the mean time, here's 25 clinical trials for oncolytic viral therapies for pancreatic cancer:

    https://clinicaltrials.gov/search?cond=Pancreatic%20Cancer&i...

    And here's a review article on the general concept from the lead physician-researcher in this article:

    https://pmc.ncbi.nlm.nih.gov/articles/PMC6186423/

    Adenoviruses are very easy to make with custom contents, and are used for many many purposes. However they rarely make it all the way to become a therapy in practice.

    It's always fascinating what hits the front page of HN when it comes to bio!

  • dwattttt 52 minutes ago
    An excellent source, Kurzgesagt covered the use of virology to cure cancer recently: https://youtu.be/0NY2gAftzJE?si=yeYfT4yc8_ffGmDD
  • cosmotic 38 minutes ago
    Is it normal to not report how many people received the treatment and just report the number of successes? Is this better than placebo or doing nothing?
    • goda90 26 minutes ago
      It sounds like it might've been the first three people to receive the treatment at all. 15 more are going to be given higher doses next to hunt for an optimum level.

      I think with trials involving experimental life saving treatment for terminal illnesses, doing things like control groups and placebos isn't considered particularly ethical, since you'd be giving false hope to someone who is knocking on death's door.

    • HedonicEscal8r 6 minutes ago
      It's normal for a Phase 1 trial, which evaluates safety and dosing on a small number of participants. If the drug passes, more extensive trials will be done.
    • nutjob2 11 minutes ago
      Why test against a placebo when you can test against death?

      Although not 100%, almost all terminal patients will die. If you select your test group well so they are very likely to die, then you improve the information you get from the test, favor the class of patients who are most likely to benefit from the treatment and least likely to be harmed by it overall.

  • DivingForGold 1 hour ago
    • HedonicEscal8r 38 minutes ago
      A link with no subscription wall: https://archive.ph/2Et0x
    • ksd482 59 minutes ago
      yes! what's with the original link? I thought my internet was down or browser malfunctioned. No response for 20 seconds or so.
      • _Microft 44 minutes ago
        I‘m getting 403/forbidden here.
  • phendrenad2 18 minutes ago
    I remember hearing about this way back in 2014. Science moves slowly.
  • bigbuppo 6 minutes ago
    Still no cure for... wait, what?